Latest filing published 24 Mar 2026 for Serina Therapeutics, Inc., €337. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Randall Moreadith in Serina Therapeutics, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 30 June 2025 to 23 March 2026, the count stands at 35 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 24 March 2026, the filings show an option exercise worth €337 in Serina Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 35 declarations